Norges Bank Maravai Lifesciences Holdings, Inc. Transaction History

Norges Bank

$634 Trillion
Q1 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$4.7 - $9.87 $1.41 Million - $2.95 Million	299,380 New	299,380 $1.96 Million
Q3 2023 Nov 13, 2023	SELL	$9.14 - $12.85 $12.6 Million - $17.7 Million	-1,377,539 Closed	0 $0
Q2 2023 Aug 14, 2023	SELL	$12.09 - $15.0 $12.4 Million - $15.4 Million	-1,027,824 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$12.99 - $16.48 $11.7 Million - $14.9 Million	903,760 New	903,760 $12.7 Million
Q4 2022 Feb 14, 2023	BUY	$12.5 - $24.78 $24.5 Million - $48.5 Million	1,957,399 New	1,957,399 $28 Million

Q3 2022 Nov 13, 2023	BUY	$20.6 - $30.37 $28.4 Million - $41.8 Million	1,377,539 New	1,377,539 $35.2 Million
Q2 2022 Aug 14, 2023	BUY	$26.05 - $37.48 $26.8 Million - $38.5 Million	1,027,824 New	1,027,824 $29.2 Million
Q1 2022 May 12, 2023	SELL	$24.46 - $40.92 $25.1 Million - $42 Million	-1,025,670 Reduced 52.4%	931,729 $32.9 Million
Q1 2022 May 09, 2022	SELL	$24.46 - $40.92 $22.8 Million - $38.1 Million	-931,729 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$35.0 - $45.94 $32.6 Million - $42.8 Million	931,729 New	931,729 $39 Million
Q3 2021 Nov 14, 2022	BUY	$36.8 - $60.62 $30.8 Million - $50.7 Million	836,580 New	836,580 $41.1 Million
Q3 2021 Nov 05, 2021	SELL	$36.8 - $60.62 $22.8 Million - $37.6 Million	-620,781 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$32.46 - $45.0 $20.2 Million - $27.9 Million	620,781 New	620,781 $25.9 Million
Q1 2021 May 07, 2021	SELL	$25.8 - $38.49 $2 Million - $2.98 Million	-77,418 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$24.5 - $30.86 $1.9 Million - $2.39 Million	77,418 New	77,418 $2.17 Million

Others Institutions Holding MRVI

# of Institutions

227

Shares Held

135M

Call Options Held

339K

Put Options Held

148K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $919M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account